Bright Green Corp
Healthcare · Medicinal Chemicals & Botanical Products · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Operating income | −$8.9M | −$27.3M | −$2.5M |
| Net income | −$13.1M | −$27.7M | −$2.5M |
| Total assets | $17.4M | $22.8M | $8.8M |
| Total liabilities | $6.4M | $11.2M | $560,156 |
| Equity | $11.0M | $11.6M | $8.2M |
| EPS (diluted) | $-0.07 | $-0.17 | $-0.02 |
| Shares out. | 174.4M | 173.3M | 157.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- —
- Net margin
- —
- Return on equity
- −119.7%
- Return on assets
- −75.4%
- Return on capital (ROCE)
- −79.6%
- Liabilities / assets
- 37.0%
- Debt / equity
- 0.59×
- Book value / share
- $0.06
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -12.74distress
- Accruals / assets
- −61.3%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 16, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 2, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMar 21, 2025
- Entered a material agreement · Bankruptcy or receivershipFeb 27, 2025
- Entered a material agreement · Bankruptcy or receivershipJan 28, 2025
- Director / officer change · Regulation FD disclosureDec 27, 2024
- Shareholder voteNov 18, 2024
- Entered a material agreement · New financial obligation · Unregistered equity sale · Amended charter or bylawsSep 18, 2024
- Entered a material agreement · New financial obligation · Delisting / listing-standard noticeAug 19, 2024
- Other material eventMay 30, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.